Cargando…

Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity

Anti-CD20 therapy using rituximab directly targeting B cells has been approved for treatment of non-Hodgkin lymphoma, rheumatoid arthritis and anti-neutrophil cytoplasmic antibody-associated vasculitides and has led to reappreciation of B-lineage cells for anti-rheumatic treatment strategies. Moreov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Henrik E, Schmidt, Stefanie, Dörner, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535716/ https://www.ncbi.nlm.nih.gov/pubmed/23281743 http://dx.doi.org/10.1186/ar3909

Ejemplares similares

Targeting autoreactive germinal centers to curb autoimmunity
por: Degn, Søren E., et al.
Publicado: (2017)

NK Cell Autoreactivity and Autoimmune Diseases
por: Poggi, Alessandro, et al.
Publicado: (2014)

Targeted suppression of autoreactive CD8(+) T-cell activation using blocking anti-CD8 antibodies
por: Clement, Mathew, et al.
Publicado: (2016)

CD138 promotes the accumulation and activation of autoreactive T cells in autoimmune MRL/lpr mice
por: Xie, Tianhong, et al.
Publicado: (2023)

Impact of cellular therapies on autoreactive, long-lived plasma cells in autoimmune diseases (AID)
por: Hiepe, F, et al.
Publicado: (2004)

Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases
por: Alonso-Ramirez, Ruby, et al.
Publicado: (2010)

T-cell Metabolism as a Target to Control Autoreactive T Cells in β-Cell Autoimmunity
por: Bordignon, Carlotta, et al.
Publicado: (2017)

Anti‐inflammatory and immune‐modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation
por: Ehteshamfar, Seyed‐Morteza, et al.
Publicado: (2020)

MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity
por: Tsai, Sue, et al.
Publicado: (2013)

Identification of Autoreactive B Cell Subpopulations in Peripheral Blood of Autoimmune Patients With Pemphigus Vulgaris
por: Pollmann, Robert, et al.
Publicado: (2019)

Targeting CD22 as a strategy for treating systemic autoimmune diseases
por: Dörner, Thomas, et al.
Publicado: (2007)

Dracocephalum heterophyllum (DH) Exhibits Potent Anti-Proliferative Effects on Autoreactive CD4(+) T Cells and Ameliorates the Development of Experimental Autoimmune Uveitis
por: Bian, Jiang, et al.
Publicado: (2020)

Pathogenic memory plasma cells in autoimmunity
por: Chang, Hyun-Dong, et al.
Publicado: (2019)

CD24 Controls Expansion and Persistence of Autoreactive T Cells in the Central Nervous System during Experimental Autoimmune Encephalomyelitis
por: Bai, Xue-Feng, et al.
Publicado: (2004)

IgE Autoreactivity in Atopic Dermatitis: Paving the Road for Autoimmune Diseases?
por: Pellefigues, Christophe
Publicado: (2020)

Genetic correlates of autoreactivity and autoreactive potential in human Ig heavy chains
por: Volpe, Joseph M, et al.
Publicado: (2009)

CD28 and ITK signals regulate autoreactive T cell trafficking
por: Jain, Nitya, et al.
Publicado: (2013)

PI3Kγ Drives Priming and Survival of Autoreactive CD4(+) T Cells during Experimental Autoimmune Encephalomyelitis
por: Comerford, Iain, et al.
Publicado: (2012)

Mercury-induced autoreactive anti-class II T cell line protects from experimental autoimmune encephalomyelitis by the bias of CD8+ antiergotypic cells in Lewis rats
Publicado: (1993)

Induction of autoreactive B cells allows priming of autoreactive T cells
Publicado: (1991)

Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity
por: Solé, Patricia, et al.
Publicado: (2021)

Controlling Autoreactivity of CD4 T Cells by Local Tolerance Induction
por: FöRster, Irmgard
Publicado: (1998)

CD1a autoreactivity: When size does matter
por: Gapin, Laurent
Publicado: (2021)

Antibody Therapies in Autoimmune Inflammatory Myopathies: Promising Treatment Options
por: Zeng, Rachel, et al.
Publicado: (2022)

Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3
por: Kadowaki, Atsushi, et al.
Publicado: (2016)

Engineering autoreactive T and B cell responses toward active immunotherapy for inflammatory diseases
por: Chang, Jason Y. H., et al.
Publicado: (2021)

GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells
por: Arif, Sefina, et al.
Publicado: (2020)

Effects of Early and Delayed Antiretroviral Therapy on Plasma Anti-CD4 Autoreactive IgG and Its Association With CD4(+) T-Cell Recovery in Acute HIV-Infected Individuals
por: Song, Aixin, et al.
Publicado: (2020)

B cell-targeted therapies in autoimmunity: rationale and progress
por: Fiorina, Paolo, et al.
Publicado: (2009)

Continuous Activation of Autoreactive CD4(+) CD25(+) Regulatory T Cells in the Steady State
por: Fisson, Sylvain, et al.
Publicado: (2003)

In Autoimmune Diabetes Unique Autoreactive T Cells Recognize Insulin Peptides Generated in the Islets of Langerhans
por: Mohan, James F., et al.
Publicado: (2010)

Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver
por: Preti, Max, et al.
Publicado: (2021)

c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells
por: Benkhoucha, Mahdia, et al.
Publicado: (2020)

Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
por: Liu, Rongzeng, et al.
Publicado: (2022)

Evidence for Selective Transformation of Autoreactive Immature Plasma Cells in Mice Deficient in Fasl
por: Zhang, Jian Qiao, et al.
Publicado: (2004)

Targeted Immunotherapy for Autoimmune Disease
por: Jung, Seung Min, et al.
Publicado: (2022)

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2006)

Spontaneous Regression of Primary Autoreactivity during Chronic Progression of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Tuohy, Vincent K., et al.
Publicado: (1999)

Direct Ex Vivo Analysis of Activated, Fas-sensitive Autoreactive T Cells in Human Autoimmune Disease
por: Bieganowska, Katarzyna D., et al.
Publicado: (1997)

Autoimmunity-Associated LYP-W620 Does Not Impair Thymic Negative Selection of Autoreactive T Cells
por: Wu, Dennis J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0ldqcpj8eutapnkges12mnii0u